Records containing: Melanoma
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2025-06-26Clinical Study to Evaluate the Safety and Efficacy of Autologous Tumor-infiltrating Lymphocyte (CT-SP) in Patients With Refractory Melanoma Who Failed to Immune Checkpoint Inhibitors
-
CLINICAL_TRIALS study record update · 2025-06-22Education for Prevention of Melanoma in Hispanic Populations
-
CLINICAL_TRIALS study record update · 2025-06-19A Phase 1/2 Study of BMS-986253 in Combination With Nivolumab or Nivolumab Plus Ipilimumab in Advanced Cancers
-
CLINICAL_TRIALS study record update · 2025-06-15A Phase 1/2 Study of BA3071 in Patients With Solid Tumors
-
CLINICAL_TRIALS study record update · 2025-06-13A Phase I, Open-label, Dose Escalation Study of Oral LGK974 in Patients With Malignancies Dependent on Wnt Ligands
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2025-06-08A Phase I, Open Label, Single Center and Dose Escalation Study Investigating Tolerance and Pharmacokinetics of Single and Multiple Doses of Recombinant Humanized Anti-PD-1 Monoclonal Antibody for Injection in Patients With Advanced Solid Tumors
-
CLINICAL_TRIALS study record update · 2025-06-06A Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetic, and Preliminary Efficacy of BA1302 in Patients With Advanced Solid Malignancies
-
CLINICAL_TRIALS study record update · 2025-06-05Randomized Phase III Trial of Standard Immunotherapy (IO) by Checkpoint Inhibitors, Versus Reduced Dose Intensity of IO in Patients With Locally Advanced or Metastatic Cancer in Response After 6 Months of Standard IO
-
CLINICAL_TRIALS study record update · 2025-05-31ClinicalTrials.gov study NCT03593499
-
CLINICAL_TRIALS study record update · 2025-05-29Blocking TNF to Potentiate the ICI-dependent Immune Awakening in Melanoma
-
CLINICAL_TRIALS study record update · 2025-05-29A Phase 1/2 Dose-Finding Study Followed by Expansion Cohorts of NGM120, a GFRAL Antagonist Monoclonal Antibody Blocking GDF15 Signaling, in Subjects With Advanced Solid Tumors and Pancreatic Cancer Using Combination Therapy
-
CLINICAL_TRIALS study record update · 2025-05-21A Randomised, Open-Label, Phase 2 Study of Ceralasertib Monotherapy and Ceralasertib Plus Durvalumab in Patients With Unresectable or Advanced Melanoma and Primary or Secondary Resistance to PD-(L)1 Inhibition
-
CLINICAL_TRIALS study record update · 2025-05-16Videoendoscopic Radical Inguinal Lymphadenectomy Versus Open Radical Inguinal Lymphadenectomy in Patients With Penile Cancer: a Feasibility Randomised Controlled Trial
-
CLINICAL_TRIALS study record update · 2025-05-16A Phase II Study to Evaluate the Safety, Tolerability, and Efficacy of IBI363 in Subjects With Advanced Melanoma
-
CLINICAL_TRIALS study record update · 2025-05-13A Phase 3 Trial of Fianlimab (Anti-LAG-3) and Cemiplimab Versus Pembrolizumab in the Adjuvant Setting in Patients With Completely Resected High-risk Melanoma
-
CLINICAL_TRIALS study record update · 2025-05-08Prospective Evaluation of Hypoxia in Primary Melanoma
-
CLINICAL_TRIALS study record update · 2025-05-08Evolution of Metabolic and Immune Dysfunction in In-transit Melanoma
-
CLINICAL_TRIALS study record update · 2025-05-08Melanoma Surveillance Photography (MSP) to Improve Early Detection of Melanoma in Ultra-high and High Risk Patients
-
CLINICAL_TRIALS study record update · 2025-05-07Sentinel Lymph Node Localization and Biopsy for Conjunctival and Eyelid Melanoma
-
CLINICAL_TRIALS study record update · 2025-05-06A Phase I Study of the Combination of Chemoradiotherapy With Biologic Therapy for Advanced Head and Neck Cancer
-
CLINICAL_TRIALS study record update · 2025-05-06Neoadjuvant Immunotherapy With Intratumoral Tavokinogene Telseplasmid (Tavo) Plus Electroporation in Combination With Intravenous Nivolumab in Patients With Operable Locally- Regionally Advanced Melanoma
-
CLINICAL_TRIALS study record update · 2025-05-04An Adapted Evidenced-Based Mentored Community Gardening Intervention for Skin Cancer Survivors: A Single-Arm Feasibility Study (Harvest for Health Together Arizona)
-
CLINICAL_TRIALS study record update · 2025-05-02Quantifying Systemic Immunosuppression to Personalize Cancer Therapy
-
CLINICAL_TRIALS study record update · 2025-05-01Survival Monitoring in Russian Cancer Registries
-
CLINICAL_TRIALS study record update · 2025-04-27Investigation of Associations Between Chemotherapy-Induced Nausea in Patients With Genitourinary, Sarcoma or Melanoma Cancers and Changes in Gut Microbiome: Potential for Precision Therapeutics